Virtual CME Program
1.00 CME/CE Credit
As part of its partnership with the Centers for Disease Control and Prevention’s Let’s Stop HIV Together campaign, Dr. Demetre Daskalakis, Director of the Division of HIV Prevention, will join Pri-Med faculty Dr. Greg Hall, expert in African American health and healthcare, as they discuss strategies for stopping the HIV epidemic across all communities. In this session, you’ll explore the concept of HIV as a syndemic and how that framework can help you identify patients with risk factors for HIV. You’ll also learn the importance of applying a status neutral approach to HIV care to ensure effective treatment and prevention of HIV across all patient populations. You’ll also leave the session with information on the latest guidelines and recommendations, including the newly released guidelines on HIV prevention with PrEP. It’s a can’t-miss educational opportunity for anyone looking for practical tools to help your patients and help end the HIV epidemic.
This session is designed to satisfy CME/CE requirements on HIV/AIDS, Infectious Diseases or Risk Management. Please check with your state licensing board for their specific requirements and print this page as documentation as might be needed.
1.00 AMA PRA Category 1 Credits™, 1.00 ABIM MOC or 1.00 AANP, including 0.25 AANP Pharm
Release Date: 2/11/2022
Expiration Date: 2/11/2025
This session is designed to satisfy CME/CE requirements on HIV/AIDS, Infectious Diseases or Risk Management. Please check with your state licensing board for their specific requirements and print this page as documentation as might be needed.
FL: HIV/AIDS (MD, DO, NP, PA).
This online activity is approved by the Florida Boards of Medicine and Nursing. Approved 2/11/22-2/11/25; CE Broker Provider #50-27480, Activity #20-1076400.
Director, Division of HIV/AIDS Prevention (DHAP)
Centers for Disease Control and Prevention
Atlanta, GA
Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH
Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH
Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH
The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.
Demetre C. Daskalakis, MD, MPH: No relevant financial relationships disclosed.
Gregory L. Hall, MD: Independent Contractor with AstraZeneca.
Ty J. Gluckman, MD, FACC, FAHA (moderator): No relevant financial relationships disclosed.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 040308.
This activity is approved for 1.00 contact hour of continuing education, which includes 0.25 hour of pharmacology.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients. Data, indications, and guidelines presented in this activity are current as of the activity release date and they are subject to change as new information is published.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.
